Cartalax
Also known as AED, Ala-Glu-Asp, Alanyl-glutamyl-aspartic acid, T-31
Cartalax is a joint-rescue peptide formulated to rebuild cartilage, reduce joint inflammation, and restore the mobility you lose with age or arthritis. Made from a simple three-amino-acid sequence, it’s deceptively powerful—it activates genes responsible for producing collagen, the structural protein that gives cartilage its cushioning strength and flexibility.
Route
Subcutaneous injection
Dose range
1 mg – 2 mg
Frequency
Once daily (subcutaneous)
Cycle length
10–20 days
Overview
Cartalax is a joint-rescue peptide formulated to rebuild cartilage, reduce joint inflammation, and restore the mobility you lose with age or arthritis. Made from a simple three-amino-acid sequence, it’s deceptively powerful—it activates genes responsible for producing collagen, the structural protein that gives cartilage its cushioning strength and flexibility. By boosting collagen production while simultaneously blocking the enzymes that destroy cartilage (matrix metalloproteinases), Cartalax hits the problem from both directions at once. It also calms inflammatory signals driving joint pain and stiffness, making movement easier and less painful within weeks of consistent use.
What makes Cartalax unique is its influence over calcium metabolism through thyroid cells, supporting bone density alongside cartilage repair—addressing both sides of joint health simultaneously. People with osteoarthritis, rheumatoid arthritis, sports injuries, or age-related joint wear report improved flexibility, reduced swelling, and restoration of pain-free movement. It prevents programmed cell death in stressed chondrocytes (the cells that make cartilage), essentially keeping your joint cells alive longer so they can continue repairs. Unlike steroid injections that provide temporary relief at the cost of long-term cartilage damage, Cartalax promotes genuine tissue regeneration. Administered via injection or orally, it works progressively over months, rebuilding the structural integrity of joints rather than just masking pain. For anyone with creaky knees, bad hips, or hands that ache, Cartalax offers a science-backed path to restored joint health and reclaimed mobility.
Studied benefits
- Reduces markers of cellular aging (senescence)
- supports fibroblast proliferation and healthy extracellular matrix balance
Reported side effects
- Limited to preclinical data
- described as well-tolerated with potential for minor injection-site itching or redness
Protocol
Dosing Schedule (Subcutaneous)
Educational reference only. Not medical advice. Research compounds are not approved for human use. Full disclaimer.
Cartalax (20mg)
Reconstitute with 2.0 mL bacteriostatic water (Final concentration: 10 mg/mL).
Support connective-tissue homeostasis and fibroblast function based on preclinical bioregulator research.
| Phase | Daily Dose (mg) | Draw at 10 mg/mL | Log |
|---|---|---|---|
| Standard Protocol | 1 mg | 10 units (0.1 mL) | + Log |
| High Dose Protocol | 2 mg | 20 units (0.2 mL) | + Log |
Frequency
Once daily (subcutaneous).
Timing
Morning injection is standard.
Cycle length
10–20 days.
Unit calculator
Set your vial and water; the table above updates.
10 mg/mL
20 doses of 1 mg per vial
Assumes a U-100 insulin syringe (100 units = 1 mL). Educational math only; verify every calculation yourself.
Context
Lifestyle considerations
Maintain a high-protein, balanced diet rich in joint-supporting micronutrients like Vitamin C, Manganese, and Glucosamine to provide the necessary substrate for connective tissue repair. Stay physically active with joint-friendly, low-impact exercises like cycling or swimming to maintain range of motion and stimulate synovial fluid circulation. Ensure 7–9 hours of quality sleep to support the body’s circadian repair of cartilage and bone structures. Avoid inflammatory foods and maintain a healthy body weight to reduce mechanical stress on the joints while the peptide supports localized cellular regeneration.
Evidence
Research summaries
Peptide Regulation of Connective Tissue and Cartilage Regeneration
Findings: Helps repair damaged joints, rebuilds cartilage shock absorbers, and keeps connective tissue flexible and strong.
Imagine the cartilage in your knees and elbows as a rubbery cushion that stops bones from grinding together. Over time, or from sports injuries, this cushion wears down, leading to pain. Cartalax, a tiny peptide made of just three amino acids (Ala-Glu-Asp), acts like a foreman at a construction site for these cushions. Research shows that it penetrates deep into cartilage cells (chondrocytes) and flips the switches on specific genes responsible for making collagen—the "steel beams" of your body's tissue. In studies looking at connective tissue cells (fibroblasts), Cartalax encouraged them to multiply and repair faster rather than dying off from old age or stress. This means that instead of just masking pain with medicine, the peptide helps the body actually patch the wear and tear. For a young athlete, this could mean recovering from joint soreness faster; for an older person, it helps keep joints moving smoothly without the "creaky" feeling. The study highlights its ability to work at the DNA level to restore the natural rhythm of tissue repair.
Read the study ↗Effects of Short Peptides on Bone and Cartilage Healing in Animal Models
Findings: Speeds up bone healing, increases bone density, and reduces inflammation that destroys joints.
When a bone breaks or a joint gets inflamed, the body rushes to fix it, but sometimes the process is too slow or messy, leaving weak spots. Cartalax helps organize this chaos. In experiments with bone defects in rats, peptides similar to Cartalax were shown to boost the volume of new bone formed over 12 weeks. It works by balancing the cells that build bone (osteoblasts) and the ones that clear away old, damaged bone (osteoclasts). It also lowers the level of "matrix metalloproteinases" (MMPs)—enzymes that act like Pac-Man, eating away at healthy cartilage during inflammation. By stopping these enzymes, Cartalax protects the joint from further damage while the repair crew gets to work. This dual action—building up the good stuff and stopping the bad stuff—makes it a promising tool for treating arthritis or helping bones knit back together stronger after a fracture. It’s like giving your skeleton a better blueprint and better tools to fix itself.
Read the study ↗Cartalax and Anti-Aging Effects in Connective Tissue Cells
Findings: Slows down cell aging, improves skin and tendon elasticity, and boosts cell survival under stress.
Your body’s tissues get stiffer and more fragile as you age because the cells get "tired" and stop dividing. Cartalax is known as a "geroprotector," which is a fancy word for something that protects against aging. Research on skin and tendon cells showed that adding Cartalax made older cells act young again. It increased their ability to divide and make fresh tissue proteins. It also reduced "apoptosis," which is when cells give up and self-destruct. By keeping these supportive cells alive and active longer, Cartalax helps maintain the elasticity of skin and the snap of tendons. For high schoolers, this science is relevant because it shows how we might one day prevent injuries from overuse in sports by keeping our connective tissues resilient, like a new rubber band instead of an old, dried-out one.
Read the study ↗More references (6)
- Short peptides in the treatment of joint degeneration, 2020
- Effect of Cartalax on cartilage tissue differentiation, 2017
- Geroprotective action of cartilage peptides, 2015
- Cartalax in patients with osteoarthritis, 2012
- Influence of short peptides on connective tissue, 2008
- Structure and function of Cartalax peptide, 2005
Identification
Chemistry
- common names
- Cartalax, AED, Ala-Glu-Asp, Alanyl-glutamyl-aspartic acid, T-31, AC-4, Cartilage bioregulator, Khavinson cartilage peptide
- cas
- Not assigned (novel research compound without standard CAS registry); alternatively referenced as SCHEMBL5324601 or PubChem CID 87815447
- formula
- C₁₂H₁₉N₃O₈
- molecular weight
- 333.29-333.3 g/mol
- sequence
- -
- source
- Fully synthetic; not naturally occurring as isolated peptide
- biosynthesis
- Produced via solid-phase peptide synthesis (SPPS)
Keep exploring
Related peptides
AOD-9604
AOD 9604 · Tyr-hGH fragment 177-191
- Route
- Subcutaneous
- Dose
- 200 mcg – 500 mcg
- Cycle
- 8–12 weeks
BPC-157
Bepecin · PL-14736
- Route
- Subcutaneous
- Dose
- 250 mcg – 1 mg
- Cycle
- 8–12 weeks
BPC-157, TB-500
- Route
- Subcutaneous
- Dose
- 333 mcg – 667 mcg
- Cycle
- 8–12 weeks
Bronchogen
AEDL · Ala-Glu-Asp-Leu peptide
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 10–20 days; often repeated every 4–6 months